These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25634708)

  • 61. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Update on Attention-Deficit/Hyperactivity Disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2014 Aug; 25(2):502-19. PubMed ID: 27132328
    [No Abstract]   [Full Text] [Related]  

  • 63. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 64. Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder.
    Ahmed R; McCaffery KJ; Aslani P
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):163-78. PubMed ID: 23560602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thinner Medial Temporal Cortex in Adolescents With Attention-Deficit/Hyperactivity Disorder and the Effects of Stimulants.
    Schweren LJ; Hartman CA; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Faraone SV; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2015 Aug; 54(8):660-7. PubMed ID: 26210335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attention deficit hyperactivity disorder: comorbidity and medication use.
    Kube DA; Petersen MC; Palmer FB
    Clin Pediatr (Phila); 2002 Sep; 41(7):461-9. PubMed ID: 12365307
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 69. Prescribing Stimulants for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Co-occurring Cannabis Use: Considerations for Managing a Clinical Dilemma.
    Dernbach MR; Gray KM; Borich A; Seery E; Russo SB; Lewis ET; Gwynette MF
    J Am Acad Child Adolesc Psychiatry; 2023 Aug; 62(8):842-846. PubMed ID: 36773700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prior treatment with stimulant medication: a much neglected confounder of studies of growth in children with attention-deficit/hyperactivity disorder.
    Poulton AS; Nanan R
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):385-7. PubMed ID: 18759649
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Can stimulant rebound mimic pediatric bipolar disorder?
    Sarampote CS; Efron LA; Robb AS; Pearl PL; Stein MA
    J Child Adolesc Psychopharmacol; 2002; 12(1):63-7. PubMed ID: 12014597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Hechtman L
    Curr Psychiatry Rep; 2006 Oct; 8(5):398-408. PubMed ID: 16968623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.
    Nutt DJ; Fone K; Asherson P; Bramble D; Hill P; Matthews K; Morris KA; Santosh P; Sonuga-Barke E; Taylor E; Weiss M; Young S;
    J Psychopharmacol; 2007 Jan; 21(1):10-41. PubMed ID: 17092962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG; Reece CE; Sawyer AC; Johnson S; Lawrence D; Zubrick SR
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):177-184. PubMed ID: 27154239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada.
    Lachaine J; Ben Amor L; Pringsheim T; Burns J; van Stralen J
    J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):730-739. PubMed ID: 31433205
    [No Abstract]   [Full Text] [Related]  

  • 76. Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy.
    Kral MC; Lally MD; Boan AD
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):735-740. PubMed ID: 28383998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Household Diversion of Prescription Stimulants: Medication Misuse by Parents of Children with Attention-Deficit/Hyperactivity Disorder.
    Pham T; Milanaik R; Kaplan A; Papaioannou H; Adesman A
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):741-746. PubMed ID: 28686059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Psychosocial treatments for attention-deficit/hyperactivity disorder.
    Knight LA; Rooney M; Chronis-Tuscano A
    Curr Psychiatry Rep; 2008 Oct; 10(5):412-8. PubMed ID: 18803915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attention-Deficit/Hyperactivity Disorder Across the Spectrum: From Childhood to Adulthood.
    Majarwitz DJ; Perumareddi P
    Prim Care; 2023 Mar; 50(1):21-36. PubMed ID: 36822725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment.
    Wilson JJ
    Am J Addict; 2007; 16 Suppl 1():5-11; quiz 12-3. PubMed ID: 17453602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.